Veracyte Stock Odds of Future Stock Price Finishing Over 51.56

VCYT Stock  USD 44.09  0.43  0.98%   
Veracyte's implied volatility is one of the determining factors in the pricing options written on Veracyte. Implied volatility approximates the future value of Veracyte based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Veracyte over a specific time period. For example, VCYT Option Call 20-12-2024 45 is a CALL option contract on Veracyte's common stock with a strick price of 45.0 expiring on 2024-12-20. The contract was last traded on 2024-12-02 at 14:29:52 for $2.0 and, as of today, has 16 days remaining before the expiration. The option is currently trading at an ask price of $0.0. The implied volatility as of the 4th of December is 16.0. View All Veracyte options

Closest to current price Veracyte long CALL Option Payoff at Expiration

Veracyte's future price is the expected price of Veracyte instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Veracyte performance during a given time horizon utilizing its historical volatility. Check out Veracyte Backtesting, Veracyte Valuation, Veracyte Correlation, Veracyte Hype Analysis, Veracyte Volatility, Veracyte History as well as Veracyte Performance.
For more information on how to buy Veracyte Stock please use our How to Invest in Veracyte guide.
  
At this time, Veracyte's Price To Operating Cash Flows Ratio is comparatively stable compared to the past year. Price To Free Cash Flows Ratio is likely to gain to 61.25 in 2024, whereas Price Book Value Ratio is likely to drop 1.82 in 2024. Please specify Veracyte's target price for which you would like Veracyte odds to be computed.

Veracyte Target Price Odds to finish over 51.56

The tendency of Veracyte Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 51.56  or more in 90 days
 44.09 90 days 51.56 
near 1
Based on a normal probability distribution, the odds of Veracyte to move over $ 51.56  or more in 90 days from now is near 1 (This Veracyte probability density function shows the probability of Veracyte Stock to fall within a particular range of prices over 90 days) . Probability of Veracyte price to stay between its current price of $ 44.09  and $ 51.56  at the end of the 90-day period is near 1 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.36 . This entails as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Veracyte will likely underperform. Additionally Veracyte has an alpha of 0.3809, implying that it can generate a 0.38 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Veracyte Price Density   
       Price  

Predictive Modules for Veracyte

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Veracyte. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Veracyte's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
40.7543.4846.21
Details
Intrinsic
Valuation
LowRealHigh
37.3540.0848.03
Details
Naive
Forecast
LowNextHigh
43.0245.7648.49
Details
11 Analysts
Consensus
LowTargetHigh
29.7332.6736.26
Details

Veracyte Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Veracyte is not an exception. The market had few large corrections towards the Veracyte's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Veracyte, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Veracyte within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.38
β
Beta against Dow Jones1.36
σ
Overall volatility
3.60
Ir
Information ratio 0.15

Veracyte Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Veracyte for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Veracyte can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
The company reported the previous year's revenue of 361.05 M. Net Loss for the year was (74.4 M) with profit before overhead, payroll, taxes, and interest of 194.95 M.
Over 99.0% of the company outstanding shares are owned by institutional investors
Latest headline from thelincolnianonline.com: Veracyte, Inc. CAO Sells 215,822.48 in Stock

Veracyte Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Veracyte Stock often depends not only on the future outlook of the current and potential Veracyte's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Veracyte's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding72.6 M
Cash And Short Term Investments216.5 M

Veracyte Technical Analysis

Veracyte's future price can be derived by breaking down and analyzing its technical indicators over time. Veracyte Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Veracyte. In general, you should focus on analyzing Veracyte Stock price patterns and their correlations with different microeconomic environments and drivers.

Veracyte Predictive Forecast Models

Veracyte's time-series forecasting models is one of many Veracyte's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Veracyte's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Veracyte

Checking the ongoing alerts about Veracyte for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Veracyte help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
The company reported the previous year's revenue of 361.05 M. Net Loss for the year was (74.4 M) with profit before overhead, payroll, taxes, and interest of 194.95 M.
Over 99.0% of the company outstanding shares are owned by institutional investors
Latest headline from thelincolnianonline.com: Veracyte, Inc. CAO Sells 215,822.48 in Stock

Additional Tools for Veracyte Stock Analysis

When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.